1. FDA, PAT – a framework for innovative pharmaceutical development, manufacturing, and quality assurance, http://www.fda.gov/cder/guidance 2004; FDA “Final report on pharmaceutical cGMPs for the 21st century – a risk-based approach”, http://www.fda.gov/cder/gmp/gmp2004/GMPfinalreport2004.htm.
2. S. Folestad, Bridging science and regulation – The PAT (R) evolution in pharma industry, APACT09, Glasgow, Scotland.
3. Near-infrared Spectroscopy: Principal, Instruments, Applications;Siesler,2002
4. Monitoring of fermentation processes producing lactic acid bacteria by mid-infrared spectroscopy;Fayolle;Vib. Spectrosc.,1997
5. Near infrared spectroscopy in fermentation and quality control for amino acid production;Schmidt;Bioproc. Eng.,1998